|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation expense | |||||
| Amortization of intangible assets | |||||
| Impairments of operating lease assets | |||||
| Impairment of property and equipment and other assets | |||||
| Impairment of intangible assets | |||||
| Stock-based compensation expense | |||||
| Inventory write downs | |||||
| Provision for doubtful accounts | |||||
| Deferred income taxes | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale-leaseback transactions | |||||
| Other | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable—trade | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Cost and estimated profits in excess of billings | |||||
| Accounts payable, deferred revenue and other accrued liabilities | |||||
| Billings in excess of costs and profits recognized | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures for property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale-leaseback transactions | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Borrowings on revolving Credit Facility | |||||
| Repayments on revolving Credit Facility | |||||
| Proceeds from issuance of 2029 Bonds | |||||
| Payments of 2025 Notes | |||||
| Proceeds from issuance of Seller Term Loan | |||||
| Payments of Seller Term Loan | |||||
| Payment of capital lease obligations | |||||
| Repurchases of stock | |||||
| Payments of withheld taxes on stock-based compensation plans | |||||
| Deferred financing costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow disclosures | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Noncash investing and financing activities | |||||
| Operating lease assets obtained in exchange for lease obligations | |||||
| Finance lease assets obtained in exchange for lease obligations | |||||
| Accrued purchases of property and equipment | |||||
| Stock issued related to business acquisition | |||||
| Liability awards converted to shares settled | |||||
Loading...